Skyepharma climbs after launching Flutiform in Spain and Italy

1st Dec 2014 12:56

Skyepharma shares moved higher on Monday after the drug-maker announced that its Flutiform product has been launched in Spain and Italy.The group also announced its 120-puff version of Flutiform has been launched in Japan by its licensing partner, Kyorin Pharmaceuticals.The drug, which is used for the treatment of bronchial asthma, is now available in 20 countries in Europe, including the five largest markets, with approvals in a further three countries.Shares had climbed 5% to 374.50p by 13:05.